Journal article
Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries?
J Chan, H Nirwati, R Triasih, N Bogdanovic-Sakran, Y Soenarto, M Hakimi, T Duke, JP Buttery, JE Bines, RF Bishop, CD Kirkwood, MD Danchin
Vaccine | ELSEVIER SCI LTD | Published : 2011
Abstract
Introduction: Past experience with live oral vaccines including licensed rotavirus vaccines demonstrates a trend towards reduced vaccine efficacy in developing countries compared with developed countries. The reasons behind this disparity are not well understood. Transplacental transfer of maternal antibodies and breast milk ingestion may attenuate vaccine responses in infants in developing countries where rotavirus infections are endemic, and maternal antibody levels are high. We examined the prevalence and level of rotavirus antibody in maternal and cord serum, colostrum and breast milk in a developing country setting. Methods: 100 mother-infant pairs were prospectively recruited from Dece..
View full abstractGrants
Awarded by Murdoch Children's Research Institute
Funding Acknowledgements
MHD holds a National Health and Medical Research Council (NHMRC) Post-doctoral Fellowship (ID 437000). CDK holds an NHMRC CDA Fellowship (ID 607347). The project was supported by a research grant from the Murdoch Childrens Research Institute, Australia.